» Articles » PMID: 10084530

Three Dimensional MRI Estimates of Brain and Spinal Cord Atrophy in Multiple Sclerosis

Overview
Date 1999 Mar 20
PMID 10084530
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The association between brain atrophy and permanent functional deficits in multiple sclerosis and the temporal relation between atrophy and the clinical disease course have seldom been investigated. This study aims to determine the amount of infratentorial and supratentorial atrophy in patients by comparison with healthy controls, to establish the relation between atrophy and disability, and to derive the rates of volume loss in individual patients from their estimated disease durations.

Methods: Three dimensional acquired MRI was performed on 20 relapsing-remitting and 20 secondary progressive multiple sclerosis patients and 10 control subjects. Volume data on infratentorial and supratentorial structures were obtained using the Cavalieri method of modern design stereology in combination with point counting. Corpus callosal sectional area and "T2 lesion load" were also determined.

Results: Significantly reduced infratentorial and cerebral white matter volumes and corpus callosal sectional areas occurred in all patients compared with controls (p=0.0001-0.004). Mean estimates of volume loss in the cohort were -21%, -19%, -46%, and -12% for the brain stem, cerebellum, upper cervical cord and white matter, respectively, and -21% for the corpus callosal sectional area. Analysis of the amount of atrophy (volume differences between patients and controls) showed that upper cervical cord and cerebral white matter atrophy correlated with the expanded disability status scale (r=-0.37 and -0.37, p=0.018-0.023) and the Scripps neurologic rating scale scores (r=+0.49 and +0.43, p=0.002-0.007). There was no relation between estimated volume loss in the supratentorial and infratentorial compartments. The "T2 lesion load" was associated with ventricular enlargement and corpus callosal atrophy (r=+0.50 and -0.55, p=0.0003-0.0012). Infratentorial atrophy rates correlated with baseline exacerbation rates (r=-0.50 to -0.48, p=0.0016-0.0021) and were higher in relapsing-remitting than secondary progressive patients (p=0.009-0.02).

Conclusions: Significant cerebral and spinal cord volume reductions occurred in both patient subgroups compared with controls. Functional correlates were found with estimated volume loss in the upper cervical cord and cerebral white matter. Particularly for infratentorial structures, estimated rates of atrophy were higher in relapsing-remitting than secondary progressive patients, suggesting that atrophy, perhaps mainly due to tract degeneration, begins early in multiple sclerosis and may relate predominantly to acute inflammatory events, with or without other gradual non-inflammatory processes later in the disease course.

Citing Articles

Brain MRI Volumetric Assessment of Patients With Multiple Sclerosis: The Volume of Basal Ganglia, Thalamus, and Posterior Fossa.

Arzpeyma S, Janeshin S, Soofi Afshar N, Saberi A, Ghalyanchi Langroodi H, Ghaffari M Basic Clin Neurosci. 2024; 14(6):741-752.

PMID: 39070194 PMC: 11273203. DOI: 10.32598/bcn.2023.1324.4.


Developing Semiautomated Methods to Measure Pre- and Postoperative Syrinx Volumes.

Kohut E, Graff S, Wakelin S, Arhin M, Nair G, Heiss J J Clin Med. 2023; 12(21).

PMID: 37959191 PMC: 10650856. DOI: 10.3390/jcm12216725.


Chronic experimental autoimmune encephalomyelitis is an excellent model to study neuroaxonal degeneration in multiple sclerosis.

Voskuhl R, MacKenzie-Graham A Front Mol Neurosci. 2022; 15:1024058.

PMID: 36340686 PMC: 9629273. DOI: 10.3389/fnmol.2022.1024058.


How changes in brain activity and connectivity are associated with motor performance in people with MS.

Peterson D, Fling B Neuroimage Clin. 2017; 17:153-162.

PMID: 29071209 PMC: 5651557. DOI: 10.1016/j.nicl.2017.09.019.


Current and Emerging Therapies in Multiple Sclerosis: Implications for the Radiologist, Part 1-Mechanisms, Efficacy, and Safety.

McNamara C, Sugrue G, Murray B, MacMahon P AJNR Am J Neuroradiol. 2017; 38(9):1664-1671.

PMID: 28408630 PMC: 7963700. DOI: 10.3174/ajnr.A5147.


References
1.
McDonald W, Miller D, Thompson A . Are magnetic resonance findings predictive of clinical outcome in therapeutic trials in multiple sclerosis? The dilemma of interferon-beta. Ann Neurol. 1994; 36(1):14-8. DOI: 10.1002/ana.410360106. View

2.
Lassmann H, Suchanek G, Ozawa K . Histopathology and the blood-cerebrospinal fluid barrier in multiple sclerosis. Ann Neurol. 1994; 36 Suppl:S42-6. DOI: 10.1002/ana.410360713. View

3.
Blatter D, Bigler E, Gale S, Johnson S, Anderson C, Burnett B . Quantitative volumetric analysis of brain MR: normative database spanning 5 decades of life. AJNR Am J Neuroradiol. 1995; 16(2):241-51. PMC: 8338340. View

4.
van Walderveen M, Barkhof F, Hommes O, Polman C, Tobi H, Frequin S . Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images. Neurology. 1995; 45(9):1684-90. DOI: 10.1212/wnl.45.9.1684. View

5.
Davie C, Barker G, Webb S, Tofts P, Thompson A, Harding A . Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. Brain. 1995; 118 ( Pt 6):1583-92. DOI: 10.1093/brain/118.6.1583. View